If you live in one of the above states, we can help you with your weight loss journey. Please call or text 319-693-8800 to learn more.
VitalUty Wellness is a comprehensive health facility known for its innovative approach to weight loss, sexual health, aesthetics, and primary care. Based in Cedar Rapids, Iowa, while also serving Arkansas, Colorado, Florida, Idaho, Maine, Montana, Nebraska, North Dakota, New Mexico, Oregon, South Dakota and Vermont the center has distinguished itself by incorporating FDA-approved Semaglutide weight loss treatments into its repertoire, offering a scientifically-backed option for those looking to manage their weight effectively.
In a recent post on June 4th, 2021 the FDA approved a new drug treatment for Weight Loss. The article from the U.S. Food and Drug Administration noted: “Today’s approval offers adults with obesity or overweight a beneficial new treatment option to incorporate into a weight management program,” said John Sharretts, M.D., deputy director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research. “FDA remains committed to facilitating the development and approval of additional safe and effective therapies for adults with obesity or overweight.” This new treatment is beyond just promising, it is proven to assist in semaglutide weight loss effectively and safely. On average 70% of American adults are overweight or obese. The health risks associated with being overweight are tremendous. Even losing 5-10% of body weight through dieting and exercise and reduce risk of cardiovascular disease.
In simple terms, Semaglutide, Wegovy or Ozempic improve insulin resistance. This allows calories and fat to be burned, while improving energy. Semaglutide is peptide that works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which targets an area of the brain that regulates appetite and food intake. By controlling blood sugar spikes and lowering blood sugar, as well as reducing appetite and cravings energy levels are more consistent. Semaglutide is administered by a subcutaneous injection, commonly dosed once weekly. Dosing may be increased after one month if needed.
The safety and effectiveness of Semaglutide have been studied in four 68-week trials. Three were randomized, double-blind, placebo-controlled (including 16-week dose escalation) and one was a randomized, double-blind, placebo-controlled withdrawal study in which patients receiving Semaglutide continued treatment or switched to placebo. In the four studies, more than 2,600 patients received Semaglutide for up to 68 weeks and more than 1,500 patients received a placebo. Semaglutide trial results showed overweight or obese adults receiving weekly semaglutide had a medium weight loss of 14.9% at 68 weeks. In this same study, nearly 70% of participants were able to achieve a 10% weight loss threshold by taking semaglutide. And 32% of participants lost at least 20% of their initial weight.
In other terms, 1 of 3 patients lose 20% of their body weight with the program. Another 1 in 2 lose 15% of their Body Weight! On average, Semaglutide alone can assist in losing 2-4 pounds a week.
Bottom line is— everyone agrees this therapy works wonders for weight loss!
Real Weight Loss results of up to 2-4 pounds per week
Powerful appetite suppressant
Improves Insulin resistance, Burns Fat and Boosts Energy
Safe & Effective Once Weekly Injection
Used in combination with VitalUty Wellness weight loss program for a High Success Rate
FDA Approved for Weight Loss
The most commonly reported side effect is weight loss. However, some have reported nausea, vomiting, diarrhea, stomach pain, or constipation. The rarest risks of serious effects increases in patients with hypoglycemia, kidney problems, and risk of allergic reactions. This medication is ideal for those who are in good health with no kidney or liver issues who wish to lose weight. The medication is not insulin and should not be used if you have type 1 diabetes or develop diabetic ketoacidosis. Consult with the medical professionals at VitalUty Wellness to see if Semaglutide injections are right for you.
Tirzepatide is a prescription medication that acts as a GIP and GLP-1 receptor agonist. Together, these effects can help control blood sugar levels, reduce appetite by slowing the digestive process, and encourage weight loss. An agonist is a medication that acts on a specific receptor to trigger a bodily response. In the case of GIP and GLP-1 agonists like Tirzepatide, they initiate the release of insulin. Glucagon-like peptide-1 (GLP-1) is a hormone made up of 30 amino acids that comes from the endocrine cells in the intestines. It belongs to a group of hormones called incretins, which help increase insulin production. Glucose-dependent insulinotropic polypeptide (GIP) is another incretin that impacts insulin production. Tirzepatide’s dual action as a GIP and GLP-1 agonist differentiates it from similar medications like Semaglutide. Some patients find that Tirzepatide provides stronger weight loss effects with less adverse effects like nausea.
Tirzepatide is a prescription medication that acts as a GIP and GLP-1 receptor agonist. Together, these effects can help control blood sugar levels, reduce appetite by slowing the digestive process, and encourage weight loss. An agonist is a medication that acts on a specific receptor to trigger a bodily response. In the case of GIP and GLP-1 agonists like Tirzepatide, they initiate the release of insulin. Glucagon-like peptide-1 (GLP-1) is a hormone made up of 30 amino acids that comes from the endocrine cells in the intestines. It belongs to a group of hormones called incretins, which help increase insulin production. Glucose-dependent insulinotropic polypeptide (GIP) is another incretin that impacts insulin production. Tirzepatide’s dual action as a GIP and GLP-1 agonist differentiates it from similar medications like Semaglutide. Some patients find that Tirzepatide provides stronger weight loss effects with less adverse effects like nausea.
Tirzepatide influences insulin production as soon as you begin taking the medication. This can lead to benefits like slowed weight gain, reduced risk of developing type-2 diabetes, and less fatigue related to blood sugar spikes throughout the day. Despite working quickly on insulin, it may take time to feel the effects of Tirzepatide. Many patients report a suppressed appetite after their first dose, but some patients don’t experience this benefit until they’ve taken Tirzepatide for a month or more. When you inject your dose, it takes around 24 hours for the medication to be fully absorbed, so the effects often begin the next day after injection.
Every patient’s experience with weight loss varies, so there is no set timeframe that applies to everyone. How quickly you lose weight depends on factors like lifestyle habits, diet, activity level, age, and other medications you may be taking. However, most people who follow a healthy diet and exercise routine begin reporting some weight loss within a month to two months of starting the medication. Anecdotally, weight loss can occur at lower doses before reaching the maximum dose, but significant weight loss is typically achieved at sustained higher doses. Regardless of when you begin to feel the effects, Tirzepatide and similar medications work best when used to encourage weight loss over time. Participants were given varying doses of Tirzepatide over the course of 72 weeks (18 months). The study participants who took 5 mg, 10 mg, or 15 mg of Tirzepatide lost an average of 15-21% of their body weight over that time. Weight loss programs should aim for long-term results rather than quickly losing weight. Rapid weight loss can lead to metabolic changes that make weight gain more common after patients stop trying to lose weight. And lifestyle changes are important in helping patients maintain their progress after they’ve reached their goal weight.
Tirzepatide is typically administered once weekly as a subcutaneous injection. The medication should be titrated, or started at a lower dose and increased over time. This helps patients avoid more intense side effects because titrating lets the body adjust over time. While protocols vary, a typical dosage starts at 2mg once weekly and is increased at four-week intervals to reach a final dose of 10-15mg. From there, patients continue to inject a weekly maintenance dose. VitalUty Wellness provides guidance on how to self-administer injections, as well as providing necessary supplies like syringes and alcohol wipes included in your order.
Begin your weight loss journey today and let the VitalUty Wellness staff help you reach YOUR weight loss Goals! Call Today 319-693-8800 for pricing or to schedule an appointment.
3555 Stone Creek Cir SW
Cedar Rapids, IA 52404
(319) 693-8800